The Sanofi Pasteur VaxDesign Campus designs, develops, and manufactures in vitro models of the human immune system. Our mission is to prevent infectious disease by forecasting vaccine responses before clinical trials, and create a competitive advantage by providing predictive in vitro immunological models and assays.

Our Modular IMmune In vitro Construct (MIMIC®) technology melds immunology with engineering to find elegant solutions to complex biological problems. MIMIC® models can predict the immune response of an individual or selected group to a drug candidate or vaccine candidate. We believe that these MIMIC® predictions can provide clinically relevant information much earlier in the development process, enabling more efficient and effective clinical development decisions. The result to our customers will be better drugs and vaccines, developed faster and at a lower cost than is possible today.

Publications 26 show all

  • 5
    Dendritic Cells/immunology
  • 3
    Antibodies, Viral/immunology
  • 3
    Models, Immunological
  • 2
    CD4-Positive T-Lymphocytes/immunology
  • 2
    Influenza Vaccines/immunology
  • 2
    Titanium/immunology
  • 1
    Adaptive Immunity/immunology
  • 1
    Adjuvants, Immunologic
  • 1
    Adjuvants, Immunologic/pharmacology
  • 1
    Animal Testing Alternatives

Patents 152show all

  • 88
    C12N - Microorganisms or enzymes
  • 81
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 28
    A61K - Preparations for medical, dental, or toilet purposes
  • 19
    C12M - Apparatus for enzymology or microbiology
  • 17
    C07K - Peptides
  • 8
    B01L - Chemical or physical laboratory apparatus for general use
  • 7
    Y02A - Technologies for adaptation to climate change
  • 5
    A01K - Animal husbandry
  • 4
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 1
    B29C - Shaping or joining of plastics

Contact Information

12612 Challenger Parkway, Suite 365
Orlando, FL 32826
United States

Overview

Total FundingEmployeesLast Funding DateStatus
1-10Acquired